Elevated C-reactive protein is associated with an increased intima to media thickness of the common carotid artery

Kerstin Winbeck1, Christian Kukla, Holger Poppert

  • 1Department of Neurology, Technical University of Munich, Germany. Winbeck@neuro.med.tu-muenchen.de

Insights

Elevated serum C-reactive protein (CRP) is linked to increased intima-media thickness (IMT) in neurological patients. This suggests CRP may be a marker for subclinical atherosclerosis in this population.

Area of Science:

  • Cardiovascular Medicine
  • Neurology
  • Biomarkers

Background:

  • C-reactive protein (CRP) is a marker of inflammation.
  • Intima-media thickness (IMT) of the carotid artery is an indicator of atherosclerosis.
  • The relationship between CRP and IMT in neurological inpatients requires further investigation.

Purpose of the Study:

  • To investigate the association between serum C-reactive protein (CRP) levels and intima-media thickness (IMT) in neurological inpatients.
  • To identify factors associated with increased IMT in this patient cohort.

Main Methods:

  • Cross-sectional study of 411 neurological inpatients.
  • Serum CRP levels measured within 12 hours of admission.
  • Intima-media thickness (IMT) of the common carotid artery assessed.
  • Multivariate linear regression analysis performed.

Main Results:

  • Patients with elevated CRP showed significantly higher IMT compared to those with normal CRP levels.
  • Elevated CRP, older age, smoking history, higher BMI, diabetes mellitus, and ischemic stroke were independently associated with increased IMT.

Conclusions:

  • Elevated serum CRP is associated with increased carotid artery IMT in neurological inpatients.
  • CRP may serve as a biomarker for subclinical atherosclerosis in this population.
  • These findings highlight the importance of managing inflammatory markers in neurological patients to reduce cardiovascular risk.

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...